LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 868 | 513 | 3286 | 0.1561 | -0.2396 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 2 | D03 | 72 | hr | 868 | 488 | 3505 | 0.1392 | -0.2488 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 868 | 491 | 3440 | 0.1427 | -0.2494 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 1 | I02 | 72 | hr | 868 | 407 | 3429 | 0.1187 | -0.3176 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 2 | I02 | 72 | hr | 868 | 504 | 3652 | 0.1380 | -0.2308 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP6 | 3 | I02 | 72 | hr | 868 | 470 | 3587 | 0.1310 | -0.2590 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP5 | 1 | D02 | 72 | hr | 868 | 488 | 3286 | 0.1485 | -0.2591 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP5 | 2 | D02 | 72 | hr | 868 | 510 | 3505 | 0.1455 | -0.2322 |
MDA-MB-231 | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 868 | 547 | 3440 | 0.1590 | -0.2075 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 1 | I01 | 72 | hr | 868 | 397 | 3429 | 0.1158 | -0.3261 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 2 | I01 | 72 | hr | 868 | 445 | 3652 | 0.1219 | -0.2756 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP6 | 3 | I01 | 72 | hr | 868 | 526 | 3587 | 0.1466 | -0.2171 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP5 | 1 | D01 | 72 | hr | 868 | 617 | 3286 | 0.1878 | -0.1629 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP5 | 2 | D01 | 72 | hr | 868 | 720 | 3505 | 0.2054 | -0.0887 |
MDA-MB-231 | Dasatinib | 10 | uM | LJP5 | 3 | D01 | 72 | hr | 868 | 564 | 3440 | 0.1639 | -0.1952 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 1 | B18 | 72 | hr | 868 | 1060 | 3286 | 0.3226 | 0.1096 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 2 | B18 | 72 | hr | 868 | 995 | 3505 | 0.2839 | 0.0701 |
MDA-MB-231 | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 868 | 1105 | 3440 | 0.3212 | 0.1291 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 868 | 1016 | 3286 | 0.3092 | 0.0854 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 2 | B17 | 72 | hr | 868 | 983 | 3505 | 0.2804 | 0.0637 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 3 | B17 | 72 | hr | 868 | 1192 | 3440 | 0.3465 | 0.1730 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 1 | B16 | 72 | hr | 868 | 1129 | 3286 | 0.3436 | 0.1466 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 868 | 1070 | 3505 | 0.3052 | 0.1094 |
MDA-MB-231 | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 868 | 1123 | 3440 | 0.3264 | 0.1384 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 1 | B15 | 72 | hr | 868 | 1064 | 3286 | 0.3238 | 0.1118 |